Related references
Note: Only part of the references are listed.Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis
Kendall B. Wallace
CARDIOVASCULAR TOXICOLOGY (2007)
Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes
Luca Gianni et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Achieving the goal of optimised renin system suppression: preclinical experience with a direct renin inhibitor
Friedrich C. Luft
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2006)
Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity
S Yilmaz et al.
TOXICOLOGY (2006)
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients
AH Gradman et al.
CIRCULATION (2005)
Prevention of acute adriamycin cardiotoxicity by dantrolene in rats
ME Büyükokuroglu et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2004)
Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity
PR Deepa et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2003)
Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension
DL Clement et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats
E Fadillioglu et al.
JOURNAL OF APPLIED TOXICOLOGY (2003)
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100) - Comparison with enalapril
J Nussberger et al.
HYPERTENSION (2002)
The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats
SY Saad et al.
PHARMACOLOGICAL RESEARCH (2001)
Apoptosis in adriamycin cardiomyopathy and its modulation by probucol
D Kumar et al.
ANTIOXIDANTS & REDOX SIGNALING (2001)
Share Paper
